Relative Fund Performance vs {{ fund.benchmark.peers.peerCount }} peers using {{ fund.benchmark.name }} as their benchmark.
1M | 3M | 6M | 1Y p.a. | 2Y p.a. | 3Y p.a. | 5Y p.a. | 10Y p.a. | |
Total return | -1.51% | -1.44% | -2.15% | 7.51% | -11.64% | -10.28% | 1.45% | -% |
Growth return | -1.51% | -1.44% | -2.15% | 7.51% | -11.64% | -10.28% | 1.45% | -% |
Income return | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -% |
Market index (MSCI Europe NR USD)
|
||||||||
Total return | 3.44% | 3.69% | 12.82% | 13.28% | 16.49% | 18.46% | 10.99% | 7.41% |
Type | Description |
IOOF GSS Fidelity Europe | |
Closed | |
IOOF Global One Limited | |
ASK0185AU | |
Equity Europe | |
![]() ![]() ![]() ![]() |
|
Superannuation Fund | |
22 May 2002 | |
$0.1 million (as at 28 Feb 2010) | |
$11.49555 (as at 26 Feb 2010) | |
$11.42678 (as at 26 Feb 2010) | |
Finalised |
Type | Description |
Standard entry fee | 4% |
MER | 1.53% (as at 30 Jun 2005) |
Indirect Cost Ratio (ICR) | 1.40% (as at 30 Jun 2009) |
Minimum initial investment | $3,000.00 |
Holding (as at 29 Feb 2012) | Type | % of Portfolio |
Novo Nordisk A/S | Equity | 4.47% |
Login now to view the complete list of holdings. |
The objective of the IOOF GSS Fidelity Europe managed fund is To achieve returns in excess of the MSCI Europe Index over the suggested minimum investment time period of five to seven years.
The strategy of the IOOF GSS Fidelity Europe managed fund is The Fund generally invests in a diversified selection of European Securities. Fidelity believes that markets are semi-efficient and share prices don't always reflect inherent value. Through in-house, bottom-up company research, Fidelity aims to uncover the opportunities which it believes offer the greatest scope for outperformance.
The APIR code of the IOOF GSS Fidelity Europe managed fund is ASK0185AU.
IOOF GSS Fidelity Europe’s total return last month was -1.51%. This was made up of a growth return of -1.51% and an income return of 0%. These returns were calculated as at 28 Feb 2010.
IOOF GSS Fidelity Europe’s total return for the last three months was -1.44%. This was made up of a growth return of -1.44% and an income return of 0%%. These returns were calculated as at 28 Feb 2010.
IOOF GSS Fidelity Europe’s one-year total return is 7.51%. This was made up of a growth return of 7.51% and an income return of 0%. These returns were calculated as at 28 Feb 2010.
IOOF GSS Fidelity Europe’s one-year total return is -10.28%. This was made up of a growth return of -10.28% and an income return of 0%. These returns were calculated as at 28 Feb 2010.
The asset allocation of the IOOF GSS Fidelity Europe managed fund is :
The Responsible Entity for the IOOF GSS Fidelity Europe managed fund is IOOF Global One Limited.
The IOOF GSS Fidelity Europe managed fund belongs to the Equity Europe sector/asset class.
As at 28 Feb 2010, the size of the IOOF GSS Fidelity Europe managed fund was $0.1 million.
The IOOF GSS Fidelity Europe managed fund has an inception date of 22 May 2002.
The current entry price of the IOOF GSS Fidelity Europe managed fund is $11.49555 per unit and the current exit price is $11.42678 per unit (as at 26 Feb 2010).
The current exit price of the IOOF GSS Fidelity Europe managed fund is $11.42678 per unit and the current entry price is $11.49555 per unit (as at 26 Feb 2010).
The minimum initial investment amount for the IOOF GSS Fidelity Europe managed fund is $3,000.
Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.